Introduction {#s1}
============

Tuberculous meningitis (TBM) results in death or severe disability in as many as two thirds of patients [@pone.0001173-Thwaites1]. The early diagnosis and instigation of chemotherapy is crucial to a successful outcome. In the absence of identification of drug resistance and institution of second line drug therapy, multi-drug resistant (MDR) TBM is always fatal [@pone.0001173-Thwaites2]. However TBM diagnosis is difficult: the clinical presentation is diverse, rapid tests insensitive and the differential diagnosis is broad.

Three options are currently available for the rapid diagnosis of TBM: Ziehl-Neelsen (ZN) smear, molecular assays and diagnostic algorithms. In experienced hands, using large CSF volumes (\>6 mls) and meticulous examination of slides (at least 30 minutes) the sensitivity of smear can exceed 60% [@pone.0001173-Thwaites3], [@pone.0001173-Kennedy1]. It is cheap and simple to perform. However, large volumes of CSF are rarely submitted to the laboratory, particularly from paediatric patients. Furthermore, in routine laboratories it is often not feasible to devote adequate time to examine a single specimen. Molecular techniques such as PCR assays require highly trained technicians, rigorous quality control to guard against contamination, are expensive and are not more sensitive than meticulous smear [@pone.0001173-Thwaites4], [@pone.0001173-Pai1]. Diagnostic algorithms based on simple clinical and laboratory features can be sensitive and specific [@pone.0001173-Thwaites5] but require further evaluation, particularly in HIV-infected patients and children . ZN smear and diagnostic algorithms do not allow for the microbiological isolation of *Mycobacterium tuberculosis* (*M. tuberculosis*) or identification of drug resistance. By contrast, PCR can potentially combine identification and detection of drug resistance in one test.

Commercial rapid liquid culture techniques have greatly reduced turn around times for the isolation and drug susceptibility testing of mycobacteria [@pone.0001173-Piersimoni1]. They are, however, too expensive for routine use by most national tuberculosis control programs in developing nations and tend to be used on limited numbers of specimens in national reference laboratories.

Microscopic observation drug susceptibility assay (MODS) is a technique for the cheap, rapid identification of drug resistant *M. tuberculosis* through direct drug susceptibility testing (DST) in liquid culture [@pone.0001173-Moore1]--[@pone.0001173-Moore3]. Equipment requirements are minimal: a level 2 Biological Safety Cabinet and inverse light microscope. It has low cross-contamination rates and is suitable for use in high-burden settings [@pone.0001173-Moore1].

It is unlikely that direct susceptibility testing from CSF specimens, as done with MODS on sputum specimens, will yield a high sensitivity due to the low numbers of bacilli in the primary specimen. Furthermore, in the comparative evaluation of diagnostic techniques for TBM, isolates are often seen to be positive by smear or PCR but negative by the more sensitive culture; this is thought to be due to the clumping of bacilli in aliquots of a sample [@pone.0001173-Thwaites4]. These two factors are likely to lead to many uninterpretable and false positive results in direct susceptibility testing. We have therefore evaluated MODS as a technique for the rapid identification of *M. tuberculosis* in the CSF in comparison with MGIT and LJ culture against a clinical gold standard. Following primary isolation, samples can be inoculated for further DST, either by MODS, molecular techniques or conventional phenotypic DST, where available.

Results {#s2}
=======

Two hundred and thirty samples were collected from 156 patients ([figure 1](#pone-0001173-g001){ref-type="fig"}). Sixty-one samples were from patients who were already on treatment (\>1 day) for HIV associated TBM and were therefore analysed separately. Clinical data was not available for nineteen samples and these were therefore excluded from further analysis. One follow-up sample from a patient on treatment for 2 days had a contaminated MODS culture. This sample was positive by LJ and MGIT.

![Flowchart of patients presenting to Hospital for Tropical Diseases with suspected TBM during the study showing results for standard microbiological investigations (MGIT/LJ/ZN smear) and MODS on CSF samples.](pone.0001173.g001){#pone-0001173-g001}

One hundred and fifty samples from 137 newly presenting patients remained. Fifty-seven (42%, n = 57/137) patients were deemed to have TBM by clinical diagnostic and microbiological criteria, excluding MODS ([table 1](#pone-0001173-t001){ref-type="table"}). Of these patients, 30 were ZN smear positive, 27 of which were also positive by MODS. A further 27 were diagnosed with TBM clinically or by microbiological culture; ten of these were positive by MODS. For the nine patients without microbilogical confirmation of TBM, no other pathogen was isolated from the CSF, the CSF biochemistry was consistent with TBM and there was a response to TBM therapy or evidence of concurrent pulmonary TB.

10.1371/journal.pone.0001173.t001

###### Features of 57 newly presenting patients with a final diagnosis of TBM.
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  patient number    HIV status   Final diagnosis   MODS (days)   ZN-smear   MGIT (days)   LJ (days)   CSF white cell count (cells/µl)   CSF protein (g/L)   CSF glucose (mmol/L)   CSF/blood glucose ratio                                  supplementary information
  ---------------- ------------ ----------------- ------------- ---------- ------------- ----------- --------------------------------- ------------------- ---------------------- ------------------------- ------------------------------------------------------------------------------------------
  6                    neg             TBM            Neg.         Neg.        Neg.         Neg.                    200                        1.9                  3.3                     0.36                                                  PTB, smear neg
  10                   neg             TBM            +.(4)         +.         +(10)       \+ (14)                 1450                        1.2                  0.8                      0.5                                                   miliary PTB
  12                    \+             TBM            Neg.         Neg.        Neg.        \+ (65)                  34                         1.7                   3                      0.55            
  13                    \+             TBM            Neg.         Neg.        Neg.         Neg.                     1                                              \<1                                     
  14                    \+             TBM            +.(6)         +.         +(17)        +(17)                   275                        1.1                  3.4                     0.63            
  15                    \+             TBM            +.(6)         +.         Neg.         +(13)                   110                        1.8                  5.5                     0.18                                                    PTB, died
  16                    \+             TBM            +.(3)         +.         Neg.         +(13)                   160                        2.4                  0.5                     0.10                                                       PTB
  18                   neg             TBM           +.(14)        neg         Neg.         +(57)                   270                        1.6                  0.5                     0.10            
  23                    \+             TBM            +.(7)         +.         +(18)        +(18)                   116                        1.4                  1.9                     0.31                                          PTB, dilated ventricles on CT
  30                    \+             TBM            +.(6)         +.         +(50)        Neg.                    62                         1.3                  2.2                     0.43            
  31                    \+             TBM            Neg.         Neg.        Neg.         Neg.                                               0.6                  1.5                     0.38                                                       PTB
  33                    \+             TBM            Neg.         Neg.        Neg.         Neg.                    60                         1.6                  1.7                     0.33            
  36                    \+             TBM            Neg.         Neg.        Neg.         Neg.                                               1.6                  1.5                     0.39            
  38                    \+             TBM            +.(6)         +.         +(35)        +(20)                   695                        1.4                  2.7                     0.38            
  40                   neg             TBM            +.(4)         +.         +(32)        +(18)                   750                        1.3                   2                      0.36            
  43                    \+             TBM           +.(21)        Neg.        +(29)        Neg.                    102                        1.5                  1.8                     0.30            
  44                   neg             TBM            +.(7)        Neg.        +(29)        +(37)                   650                       1.34                  1.6                      0.2                                                       PTB
  46                   neg             TBM           +.(10)        Neg.        +(17)        +(40)                   480                                             \<1                                                                      miliary TB . Abnormal CT
  52                   neg             TBM            +.(6)        Neg.        +(14)        +(31)                   60                         1.7                 \<0.5                                    
  53                   neg             TBM            Neg.         Neg.        Neg.         Neg.                    224                        2.1                  2.1                     0.40            
  55                    \+             TBM            +.(7)         +.         +(14)       \+ (14)                  675                        1.6                   2                       0.5                                                    miliary TB
  66                    \+             TBM            Neg.          +.         Neg.         +(25)                   40                         2.2                  1.3                     0.22                                                 miliary TB, died
  68                    \+             TBM            +.(7)        Neg.        +(16)        +(30)                   685                       0.95                  2.5                     0.33            
  78                    \+             TBM            +.(4)         +.         +(8)         +(14)                  2980                        2.4                  1.3                     0.30                                           CT consistent with TBM, PTB
  88                   neg             TBM            Neg.         Neg.        +(21)        +(55)                                              1.5                   2                      0.40            
  89                    \+             TBM           +.(30)        Neg.        +(21)        +(55)                   510                        1.7                  1.6                     0.29            
  92                    \+             TBM            Neg.          +.         Neg.         +(70)                                              2.3                  1.2                     0.23            
  96                    \+             TBM            Neg.         Neg.        +(31)        +(55)                   293                        1.2                  2.4                     0.49                                             CT consistent with TBM,
  105                   \+             TBM            +.(4)         +.         +(35)        +(35)                   350                        1.6                 \<0.5                                    
  106                   \+             TBM            +.(6)         +.         +(17)        +(21)                   218                        2.1                 \<0.5                                    
  127                   \+             TBM            Neg.         Neg.        +(32)        +(32)                  2010                        1.2                  2.2                     0.42                                             CT consistent with TBM,
  129                  neg             TBM            +.(7)         +.         Neg.         Neg.                                               1.5                                                          
  131                   \+             TBM            +.(8)        Neg.        +(13)        +(21)                   590                        1.4                  1.6                     0.42                                                    miliary TB
  136                   \+             TBM            +.(6)         +.         +(13)        +(17)                   375                        1.2                 \<0.5                                    
  138                   \+             TBM            +.(5)         +.         +(8)         +(26)                   180                        1.3                  1.4                     0.18                                           CT consistent with TBM, PTB
  140                   \+             TBM            Neg.         Neg.        +(28)        +(63)                   10                         0.6                  2.3                     0.38                                                    fungi neg
  141                  neg             TBM            Neg.         Neg.        Neg.         Neg.                    210                         1                   2.8                     0.64            
  143                   \+             TBM            +.(4)         +.         +(7)         +(28)                  3950                        1.4                  1.3                     0.33                                              CT consistent with TBM
  144                  neg             TBM            Neg.         Neg.        Neg.         Neg.                                               0.8                  1.6                     0.30            
  146                   \+             TBM            +.(4)        Neg.        +(15)        +(28)                   149                       0.32                  1.6                     0.22            
  148                   \+             TBM            +.(7)         +.         +(14)        +(21)                  1475                        1.2                 \<0.5                                    
  152                  neg             TBM            +.(6)        Neg.        +(14)        +(21)                   238                        0.8                 \<0.5                                    
  157                   \+             TBM            +.(7)         +.         +(11)        +(18)                  1290                        0.5                  2.5                     0.36             CT consistent with TBM, PTB, completed treatment of tuberculous lymphadenitis previously
  159                  neg             TBM            Neg.         Neg.        Neg.         Neg.                                               1.2                  2.8                     0.68            
  166                   \+             TBM            Neg.          +.         Neg.         Neg.                    140                        0.5                  2.5                     0.36                                           CT consistent with TBM, PTB
  167                   \+             TBM            +.(6)         +.         +(4)         +(17)                   340                        1.3                   2                      0.45                                              CT consistent with TBM
  176                   \+             TBM            +.(6)         +.         +(13)        +(16)                   142                        1.5                   2                      0.33            
  179                   \+             TBM            Neg.         Neg.        +(13)        Neg.                    505                        1.2                  1.8                     0.63            
  181                   \+             TBM            Neg.         Neg.        +(12)        +(27)                   284                        1.3                   3                       0.6                                             lymph node AFB smear (+)
  182                   \+             TBM            +.(5)         +.         +(12)        +(22)                                              1.5                 \<0.5                                    
  194                   \+             TBM            +.(5)         +.         +(13)        Neg.                   2460                        1.6                  1.3                     0.17                                                Encephalitis on CT
  197                   \+             TBM            +.(7)         +.         +(34)        Neg.                    233                        1.7                  1.5                     0.34            
  200                  neg             TBM            +.(6)         +.         +(15)        +(18)                   410                     not done                1.4                     0.22                                           CT consistent with TBM, PTB
  201                  neg             TBM            Neg.         Neg.        +(12)        +(15)                                              1.2                  2.1                     0.28            
  204                  neg             TBM            +.(8)         +.         +(11)        +(30)                  1065                        1.2                  3.2                     0.51            
  207                   \+             TBM            +.(7)         +.         +(24)        +(24)                   544                        1.6                  2.1                     0.29                                                 pneumonia on CXR
  211                   \+             TBM            +(5)          +.         +(22)        Neg.                    644                        0.9                  3.1                     0.62            

CXR = chest X-ray, CT = computerised tomography [of the]{.ul} brain, TBM = tuberculous meningitis, + = positive, neg = negative, AFB = Acid fast bacilli, PTB = pulmonary tuberculosis.

Eighty patients did not fulfil the diagnostic criteria for TBM and were negative by ZN smear, MODS, LJ, MGIT. Eighty-eight patients (n = 88/137, 64.2%) were HIV-infected. A summary of the patient data is presented in [tables 1](#pone-0001173-t001){ref-type="table"} (TBM patients) and 2 (other diagnoses).

When analysed by patient, sensitivity of MODS was 90.0% \[95% C.I 79.2--100\] (n = 27/30), 80.4% \[95% C.I. 68.4--91.6\] (n = 37/46) and 64.9% \[95% C.I 52.7--77.3\] (n = 37/57) against smear, culture and clinical criteria respectively ([table 3](#pone-0001173-t003){ref-type="table"}). With a clinical gold standard the sensitivity of smear was 53% \[95% C.I. 40.1--65.9\] (n = 30/57) and of both culture techniques, LJ or MGIT 70.2% \[95% C.I. 58.0--82.0\] (n = 40/57). There was 91.9% agreement between the MODS and MGIT tests, Kappa = 0.801. For MODS and LJ, agreement was 89.0%, kappa = 0.728; for MGIT and LJ there was 91.2% agreement, kappa = 0.788. Sensitivity and specificity data is summarised in [table 4](#pone-0001173-t004){ref-type="table"}.

10.1371/journal.pone.0001173.t002

###### Features of 80 newly presenting patients with a final diagnosis other than TBM.
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  patient number    HIV status         Final diagnosis         MODS (days)   smear    MGIT (days)   LJ (days)   CSF white cell count   CSF protein (g/L)   CSF glucose (mMol/L)   CSF/blood glucose ratio                     supplementary information
  ---------------- ------------ ----------------------------- ------------- -------- ------------- ----------- ---------------------- ------------------- ---------------------- ------------------------- ----------------------------------------------------------------
  1                     \+         Cryptococcal meningitis        Neg.       Crypto      Neg.         Neg.               55                   0.5                  2.2                     0.55                           Abnormal CXR, died, Cr Ag CSF (+)
  2                    neg       Herpes simplex encephalitis      Neg.        Neg.       Neg.         Neg.              115                   1.7                  3.2                     0.58                                    CSF PCR HSV (+)
  3                    neg           Bacterial menigitis          Neg.       cocci       Neg.         Neg.              820                    1                   1.92                    0.53                               blood culture: S..suis (+)
  5                     \+         Cryptococcal meningitis        Neg.       Crypto      Neg.         Neg.              253                                                                                              treatment of Latent TB for 3 months.
  7                     \+         Cryptococcal meningitis        Neg.       Crypto      Neg.         Neg.               6                    1.7                  2.5                     0.45                                     Cr Ag CSF (+)
  8                    neg           Bacterial menigitis          Neg.       gram +      Neg.         Neg.                                     2                  \<0.5                                    
  19                    \+         Cryptococcal meningitis        Neg.       Crypto      Neg.         Neg.               45                   0.7                  0.8                     0.13                                          died
  21                   neg         Cryptococcal meningitis        Neg.        Neg.       Neg.         Neg.              399                                        1.5                     0.27                                    Cr Ag serum (+)
  24                   neg           Viral Encephalitis           Neg.        Neg.       Neg.         Neg.                                    1.3                  2.3                     0.55            
  32                    \+         Cryptococcal meningitis        Neg.       Crypto      Neg.         Neg.                                                         2.6                     0.52            
  34                   neg        eosinophillic meningitis        Neg.        Neg.       Neg.         Neg.              260                   1.1                  2.2                     0.39                                       normal CXR
  37                   neg           meningoencephalitis          Neg.        Neg.       Neg.         Neg.              131                                        2.7                     0.52            
  42                    \+         Cryptococcal meningitis        Neg.        Neg.       Neg.         Neg.               64                    2                   3.4                     0.34                                    Cr Ag CSF : (+)
  47                    \+         Cryptococcal meningitis        Neg.       Crypto      Neg.         Neg.              180                                        1.2                     0.19            
  49                    \+         Cryptococcal meningitis        Neg.       Crypto      Neg.         Neg.               50                   0.4                  3.5                     0.53                                          died
  50                    \+          Bacterial meningitis          Neg.        Neg.       Neg.         Neg.                                                         low                                     
  54                    \+         Cryptococcak meningitis        Neg.       Crypto      Neg.         Neg.               21                                        3.1                     0.62                               Cr Ag CSF (+), normal CXR
  57                   neg           Viral Encephalitis           Neg.        Neg.       Neg.         Neg.               44                   0.8                  3.4                     0.50            
  61                   neg           Viral Encephalitis           Neg.        Neg.       Neg.         Neg.               89                   0.8                  1.9                     0.35            
  62                    \+        Cryptococcall meningitis        Neg.       crypto      Neg.         Neg.              147                   1.9                  3.2                     0.58                              pneumonia on CXR, normal CT
  64                    \+         Cryptococcal meningitis        Neg.        Neg.       Neg.         Neg.               47                   0.7                  2.7                     0.42                                    Cr Ag CSF : (+)
  67                    \+         Cryptococcal meningitis        Neg.       Crypto      Neg.         Neg.                                                                                                 
  72                    \+         Toxoplasmo encephalitis        Neg.        Neg.       Neg.         Neg.               16                   2.1                   3                      0.57                                    CSF: crypto (−)
  73                    \+         Cryptococcal meningitis        Neg.       Crypto      Neg.         Neg.               2                                         2.2                     0.35            
  76                    \+          Bacterial meningitis          Neg.        Neg.       Neg.         Neg.               4                    1.5                  3.2                     0.53                                    CSF: crypto (−)
  79                    \+         Toxoplasma encephalitis        Neg.        Neg.       Neg.         Neg.                                    1.7                  1.7                                                             CSF: crypto (−)
  81                    \+         Cryptococal meningitis         Neg.       Crypto      Neg.         Neg.               16                                       \<0.5                                    
  83                    \+         Cryptococcal meningitis        Neg.       Crypto      Neg.         Neg.                                                        \<0.5                                    
  84                   neg          Bacterial meningitis          Neg.        Neg.       Neg.         Neg.              531                                        2.7                     0.43            
  90                    \+            Fungal meningitis           Neg.        Neg.       Neg.         Neg.                                                         1.3                     0.21            
  91                    \+            Fungal meningitis           Neg.        Neg.       Neg.         Neg.               38                   1.4                  2.2                     0.40            
  97                   neg           Viral encephalitis           Neg.        Neg.       Neg.         Neg.                                    1.3                                                          
  98                    \+         Crypococcus meningitis         Neg.        Neg.       Neg.         Neg.               7                                         2.8                     0.61                                       Cr Ag (+)
  99                   neg           Viral encephalitis           Neg.        Neg.       Neg.         Neg.              920                   1.9                  1.5                     0.21                                 normal CXR, normal CT
  102                  neg          Bacterial meningitis          Neg.        Neg.       Neg.         Neg.               4                    0.7                  2.5                     0.63            
  108                   \+         Cryptococcal meningitis        Neg.        Neg.       Neg.         Neg.              210                   1.5                  1.3                     0.27                                     Cr Ag CSF (+)
  111                   \+          Bacterial meningitis          Neg.        Neg.       Neg.         Neg.              1735                  0.9                  3.1                     0.51            
  112                   \+            Fungal meningitis           Neg.       fungus      Neg.         Neg.               20                    2                  \<0.5                                    
  114                   \+           meningoencephalitis          Neg.        Neg.       Neg.         Neg.               4                    1.2                  1.7                     0.24                                       pneumonia
  116                   \+         Cryptococal meningitis         Neg.        Neg.       Neg.         Neg.              327                   1.8                  2.1                     0.36                                     Cr Ag CSF (+)
  117                  neg          Bacterial meningitis          Neg.       cocci       Neg.         Neg.              2500                  1.7                 \<0.5                                                alpha haemolytic streptococcus species.
  118                  neg          Bacterial meningitis          Neg.        Neg.       Neg.         Neg.              600                   1.8                  1.21                    0.14              pneumonia on CXR, BAL: Staph.aureus, Pseudomonas aeruginosa
  119                  neg        Eosinophillic meningitis        Neg.        Neg.       Neg.         Neg.                                    49                                                                                  BAL: pseudomonas.
  125                   \+               meningitis               Neg.       fungus      Neg.         Neg.               60                   0.6                 \<0.5                                    
  128                   \+         Cryptococcus meningitis        Neg.       crypto      Neg.         Neg.               11                   0.9                  2.6                     0.48                                     Cr Ag CSF (+)
  130                   \+            Fungal meningitis           Neg.        Neg.       Neg.         Neg.                                    34                                                           
  132                   \+            Fungal meningitis           Neg.       fungi       Neg.         Neg.               4                     1                   1.7                     0.30            
  134                   \+            Fungal meningitis           Neg.        Neg.       Neg.         Neg.               4                     1                   2.3                     0.53            
  139                  neg        Eosinophillic meningitis        Neg.        Neg.       Neg.         Neg.              620                   0.8                  3.0                     0.50             Abnormal CT, normal CXR, Serodiagnosis: cysticencus cellulosae
  142                  neg          Bacterial meningitis          Neg.        Neg.       Neg.         Neg.              900                   0.7                  1.7                     0.16                                       normal CXR
  145                   \+         Cryptococcal meningitis        Neg.        Neg.       Neg.         Neg.               33                  0.68                  2.9                     0.58                                CSF Culture: crypto (+)
  155                   \+                Toxoplama               Neg.        Neg.       Neg.         Neg.               4                    0.6                  3.6                     0.59            
  158                   \+        Cryptococcall meningitis        Neg.       crypto      Neg.         Neg.               11                   0.6                  2.5                     0.46                   Cr Ag (+),CSF culture (+) with crypto, normal CXR
  160                   \+         Cryptococcal meningitis        Neg.       crypto      Neg.         Neg.              140                   1.3                  0.6                     0.11                          CSF culture: Crypto (+), normal CXR
  161                  neg          bacterial meningitis          Neg.        Neg.       Neg.         Neg.               32                   0.5                  2.7                     0.30                                       normal CT
  162                  neg            Viral meningitis            Neg.        Neg.       Neg.         Neg.               70                   1.1                  2.1                     0.49                                      odema on CT
  163                  neg          Bacterial meningitis          Neg.        Neg.       Neg.         Neg.               80                   0.6                  3.1                     0.70            
  164                  neg          Bacterial meningitis          Neg.        Neg.       Neg.         Neg.              384                   0.8                  2.6                     0.57            
  171                   \+            Fungal meningitis           Neg.       fungus      Neg.         Neg.               9               not done yet              1.4                      0.4               recieved fungal treatment 12 days previously, normal CXR.
  172                   \+          Bacterial meningitis          Neg.        Neg.       Neg.         Neg.                                    0.7                  3.1                      0.6            
  173                  neg            Viral meningitis            Neg.        Neg.       Neg.         Neg.              370                    1                   2.8                     0.46            
  175                  neg           Meningoencephalitis          Neg.        Neg.       Neg.         Neg.               1                    0.3                  3.1                      0.6                                       normal CT
  184                   \+               Meningitis               Neg.        Neg.       Neg.         Neg.               4                    0.8                  3.4                     0.83            
  185                  neg           Viral Encephalitis           Neg.        Neg.       Neg.         Neg.                                    0.8                  4.1                     0.68            
  188                   \+            Fungal meningitis           Neg.       fungal      Neg.         Neg.               1                    0.6                  2.3                     0.49                              Abnormal CT, lesion on CXR,
  189                   \+            Fungal meningitis           Neg.       fungal      Neg.         Neg.                                                         1.3                                     
  190                   \+            Fungal meningitis           Neg.       fungal      Neg.         Neg.               1                    0.6                  3.2                     0.60            
  192                   \+            Fungal meningitis           Neg.       fungal      Neg.         Neg.               18                   0.8                  3.2                     0.59            
  206                  neg               Meningitis               Neg.        Neg.       Neg.         Neg.               22                   0.2                   4                      0.57            
  208                   \+            Fungal meningitis           Neg.       fungus      Neg.         Neg.              169                   1.5                   2                      0.38            
  209                   \+            Alcohol poisoning           Neg.        Neg.       Neg.         Neg.              153                   1.2                  2.3                     0.50                                       normal CXR
  215                  neg               Meningitis               Neg.        Neg.       Neg.         Neg.               22                   1.5                  1.1                     0.17                                       pneumonia
  216                  neg               Meningitis               Neg.        Neg.       Neg.         Neg.              965                   0.4                   4                      0.48            
  219                   \+          Bacterial meningitis          Neg.        Neg.       Neg.         Neg.              735                    1                   3.8                     0.36            
  220                  neg          Bacterial meningitis          Neg.        Neg.       Neg.         Neg.              8500                  0.9                  5.3                     0.55            
  222                   \+               Meningitis               Neg.        Neg.       Neg.         Neg.                                    1.2                                                          
  223                   \+           Meningoencephalitis          Neg.        Neg.       Neg.         Neg.                                    0.8                                                          
  224                  neg            Viral meningitis            Neg.        Neg.       Neg.         Neg.              142                   0.7                  3.5                     0.70                                       normal CT
  227                  neg       Herpes simplex encephalitis      Neg.        Neg.       Neg.         Neg.              220                   0.9                  2.7                     0.48                         PCR HSV (+), abnormal CT, abnormal CXR
  229                  neg           Viral Encephalitis           Neg.        Neg.       Neg.         Neg.              102                   0.9                  3.2                     0.80                                 normal CT, normal CXR

HSV = herpes simplex virus, CXR = Chest X-ray, CT = computerised tomography, Cr Ag = cryptococcus neoformans antigen, (+) = positive, Neg = negative.

10.1371/journal.pone.0001173.t003

###### Results of MODS for 137 patients presenting with suspected TBM by final diagnosis.
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  clinical diagnosis    TBM   Non-TBM   Total
  -------------------- ----- --------- -------
  MODS positive         37       0       37
  MODS negative         20      80       100
  Total                 57      80       137

10.1371/journal.pone.0001173.t004

###### Sensitivity of all techniques analysed by sample (n = 63), patient (n = 57) and HIV status. Specificity of all techniques in all cases was 100%.
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                                         Technique \[% sensitivity (no. positive samples)\]                            
  ------------------------------------- ---------------------------------------------------- ------------ ------------ ------------
  Analysis by sample (n = 63)                                52.4% (33)                       65.1% (41)    73% (43)    68.3% (43)
  Analysis by patient (n = 57)                               53.0% (30)                       64.9% (37)   70.2% (40)   70.2% (40)
  HIV negative patients only (n = 17)                        29.4% (5)                        58.8% (10)   58.8% (10)   64.7% (11)
  HIV positive patients only (n = 40)                        62.5% (25)                       67.5% (27)    75% (30)    72.5% (29)

Specificity of all techniques was 100% (n = 80/80). The sensitivity and specificity of MODS was 58.8% \[95% C.I. 35.7--82.3\] (n = 10/17) and 100% (n = 32/32) in HIV-uninfected patients and 67.5% \[95% C.I. 53.5--82.5\] (n = 27/40) and 100% (n = 48/48), in HIV-infected patients. The positive and negative predictive values were 100% and 78.7% in HIV-infected patients and 100% and 80.0% in HIV negative patients, respectively.

When analysed by sample against a clinical gold standard, the sensitivity and specificity of MODS for newly presenting patients was 65.1% \[95% C.I. 53.2--76.8\] (n = 41/63), and 100% (n = 87/87) respectively. The sensitivites by sample for smear, LJ and MGIT were 52.4% \[95% C.I. 39.7--64.3\] (n = 33/63), 68.3% \[95% C.I. 56.4--79.6\] (n = 43/63) and 73.0% \[95% C.I. 62.0--84.0\] (n = 46/63), respectively. The specificity of all methods was 100%. In 96 samples from HIV-infected patients, the sensitivity was 68.9% \[95% C.I. 55.5--82.5\] (n = 31/45) and specificity 100% (n = 51/51). In 54 samples from HIV-uninfected patients the sensitivity was 55.6% \[95% C.I. 42.7--69.3\] (n = 10/18) and specificity was 100% (n = 36/36).

The median time to detection of MODS positive cultures (n = 41) from newly presenting patients was 6 days (interquartile range 5--7 days). Ninety percent of samples (n = 37/41) were positive in ≤10 days. The median time to positive for MGIT (n = 46) and LJ cultures (n = 43) was 15.5 days (interquartile range 12--24 days) and 24 (interquartile range 18--35), respectively. MODS was significantly faster than MGIT and LJ (P\<0.01), ([Figure 2](#pone-0001173-g002){ref-type="fig"}).

![Cumulative percentage of positive cultures by day for MODS, MGIT and LJ culture.](pone.0001173.g002){#pone-0001173-g002}

The mean CSF sample volume was 4.6 mls (range 1--14 mls). For MODS positive samples the average volume was 5.2 mls (range1--14 mls) and for MODS negative samples 4.4 mls (range 1--13 mls).

Of 61 CSF samples from 27 patients on TBM therapy for between 2 days and 9 months, 16 were positive by one of the four methods. Seven samples were positive by MODS. Eight samples were positive by smear, 10 by MGIT and 9 by LJ ([table 5](#pone-0001173-t005){ref-type="table"}).

10.1371/journal.pone.0001173.t005

###### Summary of 61 follow-up samples from 27 HIV-positive patients with HIV associated TBM on \>7 days TB therapy[\*](#nt103){ref-type="table-fn"}.

![](pone.0001173.t005){#pone-0001173-t005-5}

  patient    treatment duration at sample date (days)   CSF volume (mls)   MODS (DAYS)   smear   MGIT (DAYS)   LJ (DAYS)   supplementary information
  --------- ------------------------------------------ ------------------ ------------- ------- ------------- ----------- ---------------------------
  101                           84                             4               NEG        NEG        NEG          NEG     
  113                          210                             2               NEG        NEG        NEG          NEG     
  12                            7                              3               NEG        NEG        NEG          NEG     
  12                            28                             3               NEG        NEG        NEG          NEG     
  12                            49                             3               NEG        NEG        NEG          NEG     
  12                            84                             2               NEG        NEG        NEG          NEG     
  123                           6                              6               NEG        \+         NEG          NEG                DIED
  127                           5                              4               NEG        NEG        NEG        \+ (28)   
  127                           28                             3               NEG        NEG        NEG          NEG     
  131                           6                              4               NEG        NEG      \+ (14)      \+ (21)   
  131                           28                             1               NEG        NEG       +(15)         NEG     
  143                           2                              2               cx         \+       \+ (13)      \+ (23)   
  15                            6                              5               NEG        NEG        NEG          NEG                DIED
  150                           2                              9             \+ (10)      \+       \+ (14)      \+ (21)   
  150                           5                              2               NEG        NEG        NEG          NEG     
  150                           28                             2              +(7)        \+         NEG          NEG     
  165                           42                             3               NEG        NEG        NEG          NEG     
  165                           56                             1               NEG        NEG        NEG          NEG     
  166                           3                              4               NEG        \+         NEG          NEG     
  166                           7                              3               NEG        NEG        NEG          NEG     
  166                           28                             2               NEG        NEG        NEG          NEG     
  167                           7                              2               NEG        NEG        NEG          NEG     
  167                           28                             1               NEG        NEG        NEG          NEG     
  17                            28                             2               NEG        NEG        NEG          NEG     
  194                           2                              3               NEG        \+         NEG          NEG     
  194                           6                              3               NEG        NEG        NEG          NEG     
  202                           84                             3               NEG        NEG        NEG          NEG     
  207                           2                              9             \+ (7)       \+        +(20)        +(20)    
  207                           7                              7               NEG        NEG        NEG          NEG     
  211                           7                              2               NEG        NEG        NEG          NEG     
  23                            2                              4               NEG        NEG        NEG          NEG     
  23                            28                             3               NEG        NEG        NEG          NEG     
  23                            56                             3               NEG        NEG        NEG          NEG     
  25                            70                             1               NEG        NEG        NEG          NEG     
  25                           168                             2               NEG        NEG       +(12)         NEG     
  28                           252                             5               NEG        NEG        NEG          NEG                DIED
  30                            28                             1               NEG        NEG        NEG          NEG     
  30                            42                             2               NEG        NEG        NEG          NEG     
  30                            70                             3             \+ (8)       NEG       +(17)        +(21)    
  35                            28                             5               NEG        NEG        NEG          NEG     
  41                            49                             2               NEG        NEG        NEG          NEG                DIED
  41                            70                             3               NEG        NEG        NEG          NEG                DIED
  55                            21                             3               NEG        NEG        NEG          NEG     
  55                            70                             7               NEG        NEG        NEG          NEG     
  58                            56                             3               NEG        NEG        NEG          NEG     
  58                            84                             5               NEG        NEG        NEG          NEG     
  63                            56                             2               NEG        NEG        NEG          NEG     
  66                            6                              3               NEG        NEG        NEG          NEG                DIED
  66                            28                             4             \+ (16)      NEG       +(19)         NEG                DIED
  78                            5                              6              +(6)        \+        +(16)        +(23)    
  78                            21                             2             \+ (10)      NEG        NEG          NEG     
  78                            70                             5               NEG        NEG        NEG          NEG     
  80                            56                            1.5              NEG        NEG        NEG          NEG     
  80                            56                             5               NEG        NEG        NEG          NEG     
  9                             28                             3               NEG        NEG        NEG          NEG     
  96                            7                              3               NEG        NEG        NEG          NEG     
  96                            28                             2               NEG        NEG        NEG          NEG     
  96                            56                             4               NEG        NEG        NEG          NEG     
  96                            84                             3               NEG        NEG        NEG          NEG     

TB therapy = rifampicin, isoniazid, pyrazinamide, ethambutol for 3 months, followed by rifampicin and isoniazid for 6 months. All patients also received adjunctive dexamethsone therapy.

Among the 80 patients not diagnosed with TBM, 34 had a final diagnosis of fungal menigitis, 6 viral meningitis, 14 bacterial meningitis and 3 toxoplasmosis. The majority of diagnoses in the remaining cases remained uncertain ([table 2](#pone-0001173-t002){ref-type="table"}).

Costs {#s2a}
-----

The cost per test of MODS for diagnosis was 0.53 USD per sample.

Discussion {#s3}
==========

MODS is a sensitive, rapid technique for the diagnosis of TBM. Although MGIT showed a slightly higher sensitivity in this study, the difference was not significant (65% vs. 73%, P = 0.335) and MODS is significantly faster (median 6 days vs. 15.5 days, P\<0.01). A smaller volume of deposit was innoculated into the MODS culture than the MGIT culture (100 µl versus 250 µl) and this is likely to account for the slightly lower sensitivity.

The median time to a positive MODS culture shown here is slightly faster than the median detection time of 7 days for isolation of *M. tuberculosis* from sputum samples in a large evaluation of MODS in Peru [@pone.0001173-Moore3]. This shorter time to detection is surprising due to the paucibacillary nature of CSF samples and may be because the NALC-NAOH decontamination of sputa samples reduces viability of the TB bacilli- prior decontamination is not required for CSF samples. Moore *et al*. have previously shown that the bacillary load of a sample (measured by bacilli/100fields on smear) has negligible impact on time-to culture positivity by MODS [@pone.0001173-Moore3]. It may be possible to reduce time to detection with the introduction of confirmatory biochemical or molecular tests for early confirmation of *M. tuberculosis*. Studies to evaluate these strategies are underway at our hospital.

We have previously shown serial positive mycobacterial cultures from patients on antituberculous therapy [@pone.0001173-Thwaites2], [@pone.0001173-Thwaites4]. In this study, 4/5 (80%) follow-up patients were positive after 2 days of treatment with antituberculous chemotherapy and between 3--6 days 5/9 (55.5%) patients were positive. However, after 7 days of chemotherapy positive cultures were rare; four samples (18.2%) were positive between 7 and 28 days of therapy and after 29 days only 2/24 (8.3%) were positive. Growth of the follow-up samples from HIV-positive patients in MODS culture was impaired, with short cords and slow growth; the clinical significance of these results is unclear. The utility of MODS for the follow-up of TBM patients on treatment, particularly as an early indicator of drug resistance requires further investigation.

The high sensitivity reported here will only be replicated if relatively large volumes of CSF are used. We have previously shown that the microbiological identification of *M. tuberculosis* in the CSF is highly volume-dependent [@pone.0001173-Thwaites3]. The average volume in this study was 4.6 mls, with the deposit divided into aliquots for 4 tests. The MODS plate was inoculated with only 100 µl of CSF deposit, whereas 250 µl each was used for MGIT and LJ culture. This may account for the slightly higher sensitivity of MGIT (70.2% vs 64.9%).

Cryptococcal meningitis is the second most common cause of meningitis among HIV-infected patients at our hospital ([figure 3](#pone-0001173-g003){ref-type="fig"}). Twenty-two percent (35/156) of patients here were diagnosed with fungal meningitis, all but one of whom were HIV-infected. Twenty-six of these were confirmed as cryptoccal meningitis through CSF India Ink smear or cryptococcal latex agglutination antigen test (Remel Inc., Lenexa, Kansas, USA). Dual infections with *Cryptococcus neoformans* and *M. tuberculosis* are occasionally seen in HIV--infected patients at our hospital; thus a diagnosis of cryptococcal meningitis does not exclude the possibility of TBM.

![*Cryptococcus neoformans* in MODS plate at ×400 magnification with inverted microscope.](pone.0001173.g003){#pone-0001173-g003}

This study was performed in a tertiary referral hospital by a dedicated technician who was able to examine each plate daily for growth. In routine laboratories, optimal examination schedules would need to be established to optimise sensitivity while minimising workload. Our experience suggests a four, seven, ten and fourteen day schedule would be appropriate for CSF specimens. Moore *et al.* recently showed that rates of contamination in a high-volume laboratory are not greater using MODS than other culture techniques for the isolation *M. tuberculosis* [@pone.0001173-Moore1], a finding supported by our study which showed only one contaminated culture in 230 samples (0.4%).

All the cultures isolated in MODS were confirmed to be *M. tuberculosis* by spoligotyping (data not shown). Isolation of atypical mycbacteria from CSF is extremely rare and optimal treatment has never been determined in clinical trials. Classical cording of *M. tuberculosis* in MODS is thought to be specific for identification in the hands of an experienced microscopist, however a rapid confirmatory test such as a nitrate strip test may be appropriate. This issue requires evaluation in a larger study.

In summary, MODS is an extremely promising technique for the rapid diagnosis of TBM, isolating *M. tuberculosis* from CSF within 10 days in the majority of cases at low cost (0.53 USD per sample). It is cheap, simple, sensitive, specific and applicable in low-technology laboratories. Its main advantage is the cheap, rapid microbiological isolation of *M. tuberculosis* from CSF and the potential to perform DST within a clinically useful timeframe.

Materials and Methods {#s4}
=====================

Patient recruitment and sample collection {#s4a}
-----------------------------------------

CSF samples were collected from consecutive patients (aged over 14 years) with clinically suspected TBM (defined as a combination of nuchal rigidity and CSF abnormalities) presenting to the Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam between June 1st and November 1st 2006. TBM was defined as "definite" if acid-fast bacilli were seen in the CSF. It was defined as "probable" in patients with one or more of the following: suspected active pulmonary tuberculosis on chest radiography; acid-fast bacilli found in any specimen other than the cerebrospinal fluid; clinical evidence of other extra-pulmonary tuberculosis; radiological features of TBM on computed tomography (CT) scan or magnetic resonance imaging (MRI) of the brain. TBM was defined as "possible" in patients with at least four of the following: a history of tuberculosis, predominance of lymphocytes in the cerebrospinal fluid, illness duration of more than five days, a ratio of cerebrospinal fluid glucose to plasma glucose of less than 0.5, altered consciousness, yellow cerebrospinal fluid, or focal neurological signs. All patients who fulfilled the above diagnostic criteria were treated for TBM with standard antituberculous chemotherapy and adjunctive dexamethasone. All patients were tested for antibodies to human immunodeficiency virus (HIV) as part of routine care. Those who were found to be HIV-infected were screened for inclusion in an ongoing randomised double-blind placebo-controlled trial of immediate versus deferred antiretroviral therapy for the treatment of HIV-associated tuberculous meningitis. In addition to routine biochemical tests, all CSF samples were also examined by Gram-stain and India ink stain, and cultured on blood, chocolate and sabouraud dextrose agar, to exclude bacterial and cryptococcal meningitis respectively. All samples included in this study were taken as part of routine clinical care and the study did not involve any change to routine patient care and therefore consent and ethical review was not deemed necessary.

The volume of each CSF sample was recorded, the sample centrifuged at 3,000g for 15 mins, the supernatant removed and the deposit aliquoted into 4 parts. ZN smear, LJ and MGIT culture were performed on each specimen according to methods previously described [@pone.0001173-Thwaites3].

MODS {#s4b}
----

MODS testing was performed by a technician who was unaware of the clinical diagnosis, smear and other culture results. The method was performed as described in Moore *et al*. [@pone.0001173-Moore2] with 2 minor modifications; 48 well plates were used in place of 24 and a plate sealer (Biorad optical tape, Biorad, Hercules CA, USA) was used to avoid evaporation and cross-contamination in the plate.

MODS media was prepared with 5.9 g Middlebrook 7H9 broth (Difco, Sparks, MD), 3.1 mls glycerol and 1.25 g bacto casitone (Difco, Sparks, MD) in 880 mls sterile distilled water. The media was autoclaved and stored in 22 ml aliquots at 4°C. Each new batch was tested for sterility by incubating one aliquot at 37°C for 1 week. One MODS plate was set up each day with the addition of 2.5 mls OADC (Becton Dickinson) and 500 µl PANTA antibiotic (Becton Dickinson). Nine hundred µl media was aliquoted to each well and 100 µl CSF deposit added. One positive control (H37Rv) and one negative control well (sterile distilled water) were inoculated each day. Plates were examined daily (on weekdays) for evidence of growth ([figure 4](#pone-0001173-g004){ref-type="fig"}).

![*M. tuberculosis* characteristic cording in MODS plate at ×400 magnification with inverted microscope.](pone.0001173.g004){#pone-0001173-g004}

Statistics {#s4c}
----------

The sensitivity, specificity, positive predictive value and negative predictive value for MODS were determined and compared with ZN smear and LJ and MGIT culture, using clinical diagnosis (instigation of anti-tuberculous chemotherapy) as the gold-standard. Time to result for the three culture methods was compared using Wilcoxon signed rank test. Samples were excluded where patient medical records were not available for analysis.

Costs {#s4d}
-----

The costs of the MODS assay were calculated based upon locally purchased reagents, where possible. It was assumed 40 samples were inoculated per plate, with 1 H37Rv positive control per plate and 1 negative control per row. Labour, capital equipment costs and maintenance costs were not included in the calculations which represent only the price of consumables. An inverse microscope is approximately 2,000 USD. An exchange rate of 16,000 Vietnamese Dong (VND) was used to convert costs to US dollars.

We would like to thank David Moore and Carlton Evans for advice establishing the MODS technique.
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